Kestra Medical Technologies Ltd. Common Stock (KMTS) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Kestra Medical Technologi...

NASDAQ: KMTS · Real-Time Price · USD
25.03
0.21 (0.85%)
At close: Oct 06, 2025, 3:59 PM
25.00
-0.12%
After-hours: Oct 06, 2025, 07:57 PM EDT

Kestra Medical Common Stock Cash Flow Statement

Financials in USD. Fiscal year is May - April.
Fiscal Year Q1 2026 Q4 2025 Q3 2025 Q4 2024 Q3 2024 Q1 2022 Q1 2021
Period Ending Jul 31, 2025 Apr 30, 2025 Jan 31, 2025 Apr 30, 2024 Jan 31, 2024 Jul 31, 2021 Jul 31, 2020
Net Income
-120.98M -116.77M -65.66M -43.9M -21.62M -21.09M -7.95M
Depreciation & Amortization
9.25M 10.59M 8.75M 6.87M 3.36M 192K 117K
Stock-Based Compensation
27.74M 23.53M 1.22M 761K 372K 1.82M 864K
Other Working Capital
2.55M 2.98M 2.64M 1.91M 436K 220K 902K
Other Non-Cash Items
1.31M 8.98M 2.26M 1.35M 612K 1.16M 208K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-632K 844K 4.3M 4.18M 1.48M 100K 464K
Operating Cash Flow
-83.31M -72.83M -49.13M -30.74M -15.8M -17.82M -6.3M
Capital Expenditures
-24.47M -21.28M -13.23M -9.17M -4.97M -1.9M -60K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
259K 328K 45K 45K 3K n/a n/a
Investing Cash Flow
-24.21M -20.95M -13.19M -9.12M -4.96M -1.9M -60K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
-319K -429K -423K -373K -110K -65K -9K
Other Financial Acitivies
237.76M 239.15M -563K -494K -493K 5.23M 5.07M
Financial Cash Flow
224.94M 238.72M 24.01M 24.13M 11.9M 5.16M 5.06M
Net Cash Flow
117.42M 144.94M -38.3M -15.73M -8.86M -14.56M -1.3M
Free Cash Flow
-107.78M -94.1M -62.36M -39.91M -20.76M -19.72M -6.36M